- Report
- September 2026
- 188 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 186 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 188 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 187 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 181 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 190 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 198 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- September 2026
- 196 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- September 2026
- 374 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- August 2026
- 132 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,241GBP
- Report
- October 2024
- 200 Pages
Global
From €3407EUR$3,750USD£2,929GBP
- Report
- January 2025
- 86 Pages
Global
From €3500EUR$4,126USD£3,113GBP
- Report
- February 2025
Latin America
From €8632EUR$9,500USD£7,419GBP
- Report
- May 2024
United Kingdom
From €2272EUR$2,500USD£1,952GBP
From €2272EUR$2,500USD£1,952GBP
- Report
- May 2024
Germany
From €2272EUR$2,500USD£1,952GBP
From €2272EUR$2,500USD£1,952GBP
- Report
- May 2024
Canada, Mexico, North America Canada, Mexico, North America
From €6815EUR$7,500USD£5,857GBP

The Thrombin Time test is a coagulation and hemostasis test used to measure the time it takes for a clot to form in a sample of blood. It is used to detect deficiencies in the coagulation cascade, such as those caused by heparin, fibrinogen, or factor deficiencies. The test is also used to monitor the effectiveness of anticoagulant therapy.
The Thrombin Time market is a subset of the larger coagulation and hemostasis testing market. It is a growing market, driven by the increasing prevalence of cardiovascular diseases, as well as the need for more accurate and reliable testing methods. The market is expected to benefit from the development of new technologies and products, such as automated systems and point-of-care testing.
Some of the major companies in the Thrombin Time market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, and Ortho Clinical Diagnostics. Show Less Read more